Valence8 US’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Valence8 US’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.8M	Buy	+93,378	New	+$13.9M	4.93%	6

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Valence8 US's XLV Position: Q2 2026 in Review

Valence8 US opened a new position in State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2026: 93,378 shares worth $14.8M. The stake represents 4.93% of the portfolio and ranks #6 among its holdings.

1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

Valence8 US held 93,378 shares of State Street Health Care Select Sector SPDR ETF worth $14.8M as of Q2 2026.
State Street Health Care Select Sector SPDR ETF was a new Valence8 US position in Q2 2026.
State Street Health Care Select Sector SPDR ETF made up 4.93% of Valence8 US's portfolio in Q2 2026, its #6 holding.
1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Valence8 US's 13F filing for Q2 2026, filed 6 Aug 2026.